Sponsored By

Return of the Billion Dollar Medtech Deal

MD+DI Managing Editor Omar Ford speaks out on the recent rash of billion-dollar deals medtech has seen during the COVID-19 era.

Omar Ford

August 20, 2020

It seems as if today’s climate would call for smaller tuck-in deals. But the opposite is happening in the medical devices and diagnostics.  The industry has seen larger more robust deals that are stretching past the billion-dollar mark.

Teladoc Health’s $16.5 billion bid to acquire Livongo holds the record of being one of the largest deals to be announced during the pandemic era (so far). The acquisition is fueled by the rise in demand for virtual health.

But more million-dollar deals beyond the virtual health space are happening – such as the proposed Siemens Healthineers/Varian merger.

MD+DI Managing Editor Omar Ford delves deeper to get to the bottom of this growing trend.

 

About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like